Causal modeling of CALGB 80405 (Alliance) identifies network drivers of metastatic colorectal cancer (CRC)
- Citation:
- J Clin Oncol vol 36 (Suppl) abstr 3570
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Eli Lilly and Company, Genentech, Pfizer
- Grants:
- U10CA180821, U10CA180882, U10CA180888
- Corr. Author:
- Authors:
- Federico Innocenti Heinz-Josef Lenz Jeffrey Meyerhardt Donna Niedzwiecki Andrew Nixon Eileen O'Reilly Fang-Shu Ou Alan Venook Rahul K. Das Leon Furchtgott Daniel Cunha Kelly Rich Jeanne Latourelle Diane Wuest Boris Hayete Iya Khalil
- Networks:
- CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: